ZA824446B - Heterocyclic acetic acid compounds and compositions for treating bone diseases - Google Patents

Heterocyclic acetic acid compounds and compositions for treating bone diseases

Info

Publication number
ZA824446B
ZA824446B ZA824446A ZA824446A ZA824446B ZA 824446 B ZA824446 B ZA 824446B ZA 824446 A ZA824446 A ZA 824446A ZA 824446 A ZA824446 A ZA 824446A ZA 824446 B ZA824446 B ZA 824446B
Authority
ZA
South Africa
Prior art keywords
compositions
acetic acid
acid compounds
bone diseases
treating bone
Prior art date
Application number
ZA824446A
Other languages
English (en)
Inventor
Bakir Fawzi Mahdi
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of ZA824446B publication Critical patent/ZA824446B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025Esters of poly(thio)phosphonic acids
    • C07F9/405Esters of poly(thio)phosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
    • C07F9/655354Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Furan Compounds (AREA)
ZA824446A 1981-06-23 1982-06-23 Heterocyclic acetic acid compounds and compositions for treating bone diseases ZA824446B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27655481A 1981-06-23 1981-06-23

Publications (1)

Publication Number Publication Date
ZA824446B true ZA824446B (en) 1983-04-27

Family

ID=23057100

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA824446A ZA824446B (en) 1981-06-23 1982-06-23 Heterocyclic acetic acid compounds and compositions for treating bone diseases

Country Status (4)

Country Link
EP (1) EP0068563A3 (fr)
JP (1) JPS5841862A (fr)
AU (1) AU8503982A (fr)
ZA (1) ZA824446B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0178413A1 (fr) * 1984-08-17 1986-04-23 Beecham Group Plc Benzimidazoles
AU6898287A (en) * 1986-01-30 1987-08-25 University Of Utah, The Treatment of bone loss
JPH0277048U (fr) * 1988-11-18 1990-06-13
GB8921069D0 (en) * 1989-09-18 1989-11-01 Wellcome Found Pharmaceutically active compound,preparation and use
EP0440183A1 (fr) * 1990-02-01 1991-08-07 Takeda Chemical Industries, Ltd. Composés à base d'oxazol, procédé pour leur préparation et leur utilisation
CA2038925A1 (fr) * 1990-03-26 1991-09-27 Takashi Sohda Derives d'indole; preparation et utilisation
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
USRE39049E1 (en) * 1992-07-28 2006-03-28 Eli Lilly And Company Methods for inhibiting bone loss
USRE38968E1 (en) 1992-07-28 2006-02-07 Eli Lilly And Company Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
US5478847A (en) 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
AU2004200554B2 (en) * 1999-10-11 2005-05-19 University College Dublin Electroactive Compounds
US6870657B1 (en) 1999-10-11 2005-03-22 University College Dublin Electrochromic device

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944417A (en) * 1960-10-13 1963-12-11 Smith Kline French Lab Improvements in or relating to antimicrobial compounds and processes for their preparation
FR149F (fr) * 1964-10-29
FR1516746A (fr) * 1966-04-20 1968-02-05 Rhone Poulenc Sa Nouveaux dérivés de la phénoxazine et leur préparation
GB1217689A (en) * 1967-08-14 1970-12-31 Guppo Lepetit S P A Ethyl esters of fluro-acetic acids
DE2015265A1 (de) * 1969-03-29 1970-10-08 Yoshitomi Pharmaceutical Industries Ltd., Osaka (Japan) Arylalkansäuren und Verfahren zu deren Herstellung
CH535762A (de) * 1970-09-30 1973-04-15 Sandoz Ag Verfahren zur Herstellung neuer Indolderivate
GB1327536A (en) * 1972-04-13 1973-08-22 Yoshitomi Pharmaceutical Xanthen-2-yl-propionic acids
NL7305520A (fr) * 1972-05-13 1973-11-15
DE2245940A1 (de) * 1972-09-19 1974-05-02 Merck Patent Gmbh Schwefelhaltige ringverbindungen und verfahren zu ihrer herstellung
FR2211219A1 (en) * 1972-12-21 1974-07-19 Yoshitomi Pharmaceutical Thioxanthene carboxylic acid deriv-contg compsns - useful as analgesic, anti-inflammatory and anti-rheumatic agents
CH593954A5 (fr) * 1975-07-21 1977-12-30 Ciba Geigy Ag
PL105779B1 (pl) * 1977-12-14 1979-10-31 Sposob otrzymywania nowych pochodnych benzimidazolu

Also Published As

Publication number Publication date
EP0068563A2 (fr) 1983-01-05
EP0068563A3 (fr) 1983-06-15
AU8503982A (en) 1983-01-06
JPS5841862A (ja) 1983-03-11

Similar Documents

Publication Publication Date Title
ZA824233B (en) Therapeutic method and method for making compositions for use therein
PT75827B (en) Process for the preparation of heterocyclic derivatives of phenlthiadiazinone oxadiazinone and triadiazinone and pharmaceutical compositions therewith
AU551900B2 (en) Anthralin compositions for treatment of skin diseases
ZA824446B (en) Heterocyclic acetic acid compounds and compositions for treating bone diseases
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
IL98387A0 (en) Pyridyl-benzoic acid derivatives for treating leukotriene-related diseases
DE3261760D1 (en) Pharmaceutical compositions for the treatment of skin
ZA82361B (en) Pharmaceutical composition for treating diseases of the oral cavity
GB2105992B (en) Pharmaceutical composition for treatment of cardio-vascular diseases
ZA914323B (en) Benzoic acid derivatives for treating leukotriene-related diseases
IL104132A0 (en) Compositions for the treatment of mammalian diseases
CS22891A2 (en) Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases
PT72841B (en) Process for the preparation of heterocyclic substituted thio- glycolic acid anilides and fungicide compositions cointaining same
DE3173866D1 (en) Compounds and compositions for treatment of ocular hypertension
GB2103916B (en) Treatment of straw
ZA822176B (en) Pharmaceutical compositions for the treatment of diabetes
GB2086890B (en) Derivatives of 2-(2'-oxo-ethylidene)-3-clavancarboxylic acid
IL64637A0 (en) Composition for treating external tissues
IL64638A0 (en) Composition for treating external tissues
GB2131797B (en) New heterocyclic acetic acid derivatives and process for the preparation thereof
ZA822028B (en) Process for the preparation of caronaldehyde acid and derivatives thereof
ZA857722B (en) Process for treatment of diseases
BG33029A1 (en) Means for medical treating of deformating arthroze
BG36215A1 (en) Means for treatment of gallic diseases
BG33025A1 (en) Operative method for medical treating the irretention of the urine by women